OBJECTIVE: The goal was to test the effects of high-efficiency, particulate-arresting (HEPA) air cleaners on unscheduled asthma visits and symptoms among children with asthma exposed to secondhand smoke. METHODS: We enrolled 225 eligible children who were 6 to 12 years of age, had physician-diagnosed asthma, and were exposed to ≥5 cigarettes per day. We conducted a double-blind, randomized trial. Children were assigned randomly to receive 2 active or inactive HEPA air cleaners. RESULTS: Of 225 enrolled children, 110 (49%) were assigned to the intervention group and 115 (51%) to the control group; 215 (95%) completed the trial. During the trial, there were 42 fewer unscheduled asthma visits among children in the intervention group (18.5% [95% confidence interval: 1.25%-82.75%]; P = .043), compared with those in the control group, after adjustment for baseline differences. There was a significant difference in the reductions of levels of particles of >0.3 μm according to group assignment; there was a 25% reduction in particle levels in the intervention group, compared with a 5% reduction in the control group (P = .026). There were no significant differences in parent-reported asthma symptoms, exhaled nitric-oxide levels, air nicotine levels, or cotinine levels according to group assignment. CONCLUSIONS: These results hold promise for using HEPA air cleaners as part of a multifaceted strategy to reduce asthma morbidity, but further research is necessary before they can be recommended routinely for the medical management of asthma.
RCT Entities:
OBJECTIVE: The goal was to test the effects of high-efficiency, particulate-arresting (HEPA) air cleaners on unscheduled asthma visits and symptoms among children with asthma exposed to secondhand smoke. METHODS: We enrolled 225 eligible children who were 6 to 12 years of age, had physician-diagnosed asthma, and were exposed to ≥5 cigarettes per day. We conducted a double-blind, randomized trial. Children were assigned randomly to receive 2 active or inactive HEPA air cleaners. RESULTS: Of 225 enrolled children, 110 (49%) were assigned to the intervention group and 115 (51%) to the control group; 215 (95%) completed the trial. During the trial, there were 42 fewer unscheduled asthma visits among children in the intervention group (18.5% [95% confidence interval: 1.25%-82.75%]; P = .043), compared with those in the control group, after adjustment for baseline differences. There was a significant difference in the reductions of levels of particles of >0.3 μm according to group assignment; there was a 25% reduction in particle levels in the intervention group, compared with a 5% reduction in the control group (P = .026). There were no significant differences in parent-reported asthma symptoms, exhaled nitric-oxide levels, air nicotine levels, or cotinine levels according to group assignment. CONCLUSIONS: These results hold promise for using HEPA air cleaners as part of a multifaceted strategy to reduce asthma morbidity, but further research is necessary before they can be recommended routinely for the medical management of asthma.
Authors: Melanie Wakefield; David Banham; Kieran McCaul; James Martin; Richard Ruffin; Neil Badcock; Lyn Roberts Journal: Prev Med Date: 2002-01 Impact factor: 4.018
Authors: Wanda Phipatanakul; Petros Koutrakis; Brent A Coull; Choong-Min Kang; Jack M Wolfson; Stephen T Ferguson; Carter R Petty; Mihail Samnaliev; Amparito Cunningham; William J Sheehan; Jonathan M Gaffin; Sachin N Baxi; Peggy S Lai; Perdita Permaul; Liming Liang; Peter S Thorne; Gary Adamkiewicz; Kasey J Brennan; Andrea A Baccarelli; Diane R Gold Journal: Contemp Clin Trials Date: 2017-06-12 Impact factor: 2.226
Authors: Doug Brugge; Ellin Reisner; Luz T Padró-Martínez; Wig Zamore; Emmanuel Owusu; John L Durant Journal: Prog Community Health Partnersh Date: 2013
Authors: Jennie Cox; Kelechi Isiugo; Patrick Ryan; Sergey A Grinshpun; Michael Yermakov; Colleen Desmond; Roman Jandarov; Stephen Vesper; James Ross; Steven Chillrud; Karen Dannemiller; Tiina Reponen Journal: Indoor Air Date: 2018-09-17 Impact factor: 5.770
Authors: Christine James; David I Bernstein; Jennie Cox; Patrick Ryan; Christopher Wolfe; Roman Jandarov; Nicholas Newman; Reshmi Indugula; Tiina Reponen Journal: Indoor Air Date: 2019-12-08 Impact factor: 5.770
Authors: Erin E Masterson; Lisa B Younglove; Adriana Perez; Elizabeth Torres; Jennifer E Krenz; Maria I Tchong French; Anne M Riederer; Paul D Sampson; Nervana Metwali; Esther Min; Karen L Jansen; Gino Aisenberg; Ryan S Babadi; Stephanie A Farquhar; Peter S Thorne; Catherine J Karr Journal: Contemp Clin Trials Date: 2020-07-25 Impact factor: 2.226
Authors: Iny Jhun; Jonathan M Gaffin; Brent A Coull; Michelle F Huffaker; Carter R Petty; William J Sheehan; Sachin N Baxi; Peggy S Lai; Choong-Min Kang; Jack M Wolfson; Diane R Gold; Petros Koutrakis; Wanda Phipatanakul Journal: J Allergy Clin Immunol Pract Date: 2016-09-15